Edition:
United Kingdom

Aduro Biotech Inc (ADRO.OQ)

ADRO.OQ on NASDAQ Stock Exchange Global Select Market

9.10USD
22 Nov 2017
Change (% chg)

$-0.05 (-0.55%)
Prev Close
$9.15
Open
$9.15
Day's High
$9.20
Day's Low
$8.98
Volume
72,379
Avg. Vol
102,508
52-wk High
$14.35
52-wk Low
$6.25

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.36 December 23 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 3 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.71 1.83 1.83 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 7 4.67 7.46 3.70 3.78
Quarter Ending Mar-18 3 4.73 6.70 3.75 3.70
Year Ending Dec-17 7 18.12 20.95 17.19 48.76
Year Ending Dec-18 6 38.20 74.82 15.02 58.51
Earnings (per share)
Quarter Ending Dec-17 7 -0.36 -0.30 -0.46 --
Quarter Ending Mar-18 5 -0.38 -0.36 -0.40 --
Year Ending Dec-17 7 -1.31 -1.22 -1.48 -1.32
Year Ending Dec-18 7 -1.45 -0.78 -1.81 -1.68

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 6.13 3.79 2.34 38.14
Quarter Ending Jun-17 11.19 5.92 5.28 47.14
Quarter Ending Mar-17 4.53 3.77 0.76 16.77
Quarter Ending Dec-16 3.85 3.88 0.03 0.77
Quarter Ending Sep-16 4.04 3.79 0.25 6.14

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4.67 4.67 6.09 6.09 3.78
Quarter Ending Mar-18 4.73 4.73 3.75 3.75 3.70
Year Ending Dec-17 18.12 18.12 22.30 22.30 48.76
Year Ending Dec-18 38.20 38.20 44.11 44.11 58.51

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 1
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 3 3
Year Ending Dec-18 0 0 1 2
Earnings